β-Cell DNA Damage Response Promotes Islet Inflammation in Type 1 Diabetes.
| Citation | Horwitz, Elad, et al. “β-Cell DNA Damage Response Promotes Islet Inflammation in Type 1 Diabetes”. 2018. Diabetes, vol. 67, no. 11, 2018, pp. 2305–2318. | 
| Center | Vanderbilt University | 
| Author | Elad Horwitz, Lars Krogvold, Sophia Zhitomirsky, Avital Swisa, Maya Fischman, Tsuria Lax, Tehila Dahan, Noa Hurvitz, Noa Weinberg-Corem, Agnes Klochendler, Alvin C Powers, Marcela Brissova, Anne Jörns, Sigurd Lenzen, Benjamin Glaser, Knut Dahl-Jørgensen, Yuval Dor | 
| Abstract | Type 1 diabetes (T1D) is an autoimmune disease where pancreatic β-cells are destroyed by islet-infiltrating T cells. Although a role for β-cell defects has been suspected, β-cell abnormalities are difficult to demonstrate. We show a β-cell DNA damage response (DDR), presented by activation of the 53BP1 protein and accumulation of p53, in biopsy and autopsy material from patients with recently diagnosed T1D as well as a rat model of human T1D. The β-cell DDR is more frequent in islets infiltrated by CD45 immune cells, suggesting a link to islet inflammation. The β-cell toxin streptozotocin (STZ) elicits DDR in islets, both in vivo and ex vivo, and causes elevation of the proinflammatory molecules IL-1β and Cxcl10. β-Cell-specific inactivation of the master DNA repair gene ataxia telangiectasia mutated (ATM) in STZ-treated mice decreases the expression of proinflammatory cytokines in islets and attenuates the development of hyperglycemia. Together, these data suggest that β-cell DDR is an early event in T1D, possibly contributing to autoimmunity. | 
| Year of Publication | 2018 | 
| Journal | Diabetes | 
| Volume | 67 | 
| Issue | 11 | 
| Number of Pages | 2305-2318 | 
| Date Published | 12/2018 | 
| ISSN Number | 1939-327X | 
| DOI | 10.2337/db17-1006 | 
| Alternate Journal | Diabetes | 
| PMCID | PMC6198335 | 
| PMID | 30150306 | 
| Download citation |